Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Projected Valuation Of The Peptide Antibiotics Market In The Coming Years?

In recent times, the market size of peptide antibiotics has witnessed significant growth. The market is projected to escalate from $5.25 billion in 2024 to $5.77 billion in 2025, marking a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the past period include the discovery and improvement of peptide antibiotics, growing antibiotic resistance, an increase in the occurrence of infectious diseases, advancements in peptide synthesis technologies, together with expansion of the pharmaceutical industry.

The market for peptide antibiotics is anticipated to witness considerable expansion in the approaching years, reaching a whopping $8.29 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.5%. Factors propelling this projected growth during the forecasted period comprise increased emphasis on the development of innovative antibiotics, a global rise in antibiotic-resistant infections, broader research and development on antimicrobial peptides, and regulatory backing for new antibiotic approvals. The forecast period will also witness key trends like the exploration of natural sources of antimicrobial peptides, utilization of peptide antibiotics for animal health, focusing on peptide engineering to amplify efficacy, concoction of combination peptide antibiotics, and incorporation of AI and machine learning in the discovery of peptide antibiotics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Peptide Antibiotics Market?

The surge in the incidence of various contagious diseases is anticipated to boost the peptide antibiotics market’s expansion. Contagious diseases are conditions caused by harmful organisms like bacteria, fungi, parasites, and more. The primary causes of the increase in contagious diseases include swift urbanization, climate alteration, a rising threat of disease manifestation, and more, all of which have augmented the demand for peptide antibiotics. Peptide antibiotics cause physical damage to the cell membranes, reinforcing their antibacterial performance. For example, as per the World Health Organization, a Switzerland-based global agency, the American region reported dengue cases surpassing seven million by April 2024, a notable increase from the 4.6 million cases reported throughout 2023. Thus, the surge in the occurrence of infectious diseases is fueling the growth of the peptide antibiotics market.

Which Sub-Segments Are Driving Growth Within The Peptide Antibiotics Market?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

What Future-Focused Trends Are Anticipated In The Peptide Antibiotics Market?

A growing trend in the peptide antibiotics market is the formation of strategic partnerships. Many leading companies in this market are collaborating with others, aiming to broaden their market reach and mutually benefit from each other’s resources. As an example, in January 2022, American digital cell biology company, Berkeley Lights, formed a partnership with Aanika Biosciences. This collaboration will allow Aanika to utilize Berkeley Lights’ rapid and functional screening service to quickly identify and optimize functional antimicrobial peptides (AMPs) that can eliminate harmful bacteria, including those that lead to foodborne illness outbreaks. Moreover, the Beacon Optofluidic Platform will help identify bacterial harmful peptides, leading to the creation of a unique antibacterial tag, which will subsequently be used in their bacterial spore-based barcoding technology to enhance food supply chain safety. Aanika Biosciences is a biotechnology firm based in the United States.

Which Players Are Shaping The Competitive Landscape Of The Peptide Antibiotics Market?

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

How Do Regional Dynamics Influence The Peptide Antibiotics Market Performance?

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model